Quick Takeaways
- Iroquois Capital Management, LLC filed SCHEDULE 13G/A for Bionano Genomics, Inc. Common Stock, par value $0.0001 per share (BNGO).
- Disclosed ownership: 5%.
- Date of event: 30 Sep 2025.
Iroquois Capital Management, LLC - 30 Sep 2025 SCHEDULE 13G/A Report for Bionano Genomics, Inc. Common Stock, par value $0.0001 per share (BNGO)
- Filing Manager
- Iroquois Capital Management, LLC
- Reporting Manager
- Iroquois Capital Management, LLC
- Symbol
- BNGO
- Shares outstanding
- 10,213,587 shares
- Disclosed Ownership
- 509,658 shares
- Ownership
- 5%
- Form type
- SCHEDULE 13G/A
- Filing time
- 14 Nov 2025, 14:44:57 UTC
- Date of event
- 30 Sep 2025
- Previous filing
- 18 Sep 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"Iroquois Capital Management, LLC disclosed 5% ownership in Bionano Genomics, Inc. Common Stock, par value $0.0001 per share (BNGO) on 30 Sep 2025."
What Changed
- Previous schedule filing date: 18 Sep 2025.
- Current filing was accepted on 14 Nov 2025, 14:44.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Official SEC Source
Backed by Schedule 13D/13G
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original FilingReporting Managers (3)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Iroquois Capital Management, LLC | 5% | 509,658 | 0 | 509,658 | /s/ Richard Abbe | Richard Abbe, President | |
| Richard Abbe | 5% | 509,658 | 322,528 | 509,658 | /s/ Richard Abbe | Richard Abbe | |
| Kimberly Page | 5% | 509,658 | 0 | 509,658 | /s/ Kimberly Page | Kimberly Page |